Sarepta (SRPT) Wins Key PTO Decision on Composition of Matter Patents - Oppenheimer
Go back to Sarepta (SRPT) Wins Key PTO Decision on Composition of Matter Patents - Oppenheimer| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 64.63 -1.9 (2.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.53 | 52 Week High | $108.96 | |||
| Open | $65.24 | 52 Week Low | $62.12 | |||
| Day High | $66.26 | P/E | N/A | |||
| Day Low | $64.01 | EPS | $-1.27 | |||
| Volume | 1,457,214 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 20.94 -1.56 (6.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.50 | 52 Week High | $63.73 | |||
| Open | $19.86 | 52 Week Low | $8.00 | |||
| Day High | $21.32 | P/E | N/A | |||
| Day Low | $19.51 | EPS | $-5.69 | |||
| Volume | 6,240,450 | |||||
